TABLE 4.
Disease and agent (exptl conditions, suspending medium) | Initial titer | Temp (°C) | rH (%) | T90 (h) | T99 (h) | Ki | Reference |
---|---|---|---|---|---|---|---|
Anthrax | |||||||
Bacillus anthracis (multiple hours in night air) | Complete recovery | 62 | |||||
Bacillus anthracis | 4.64 × 10−7 HPACe | 82 | |||||
Tularemia | |||||||
Francisella tularensis SCHU S5 (PBSb) | 1.5 × 1011 CFU/ml | −40 | Ambient | 1.02 | 2.05 | 0.97 | 27 |
−29 | Ambient | 3.97 | 7.93 | 0.25 | |||
−7 | Ambient | 2.68 | 5.35 | 0.37 | |||
24 | 85 | 1.80 | 3.60 | 0.55 | |||
29 | 85 | 1.10 | 2.21 | 0.90 | |||
35 | 85 | 0.48 | 0.96 | 2.08 | |||
Francisella tularensis LVS (culture medium with a wet dissemination) | 3.0 × 1010 CFU/ml | 90 | 65.6a | 131a | 0.03 | 20, 21 | |
80 | 1.91a | 3.82a | 1.20 | ||||
70 | 1.10a | 2.20a | 2.09 | ||||
60 | 0.28a | 0.57a | 8.00 | ||||
50 | 0.24 | 0.48a | 9.59 | ||||
40 | 0.24 | 0.49a | 9.39 | ||||
30 | 0.25 | 0.50a | 9.20 | ||||
20 | 0.58a | 1.16a | 3.97 | ||||
0 | 0.58a | 1.17a | 3.95 | ||||
Francisella tularensis LVS (freeze-dried in peptone broth with a dry dissemination) | 3.0 × 1010 CFU/ml | 90 | 0.37a | 0.74a | 6.15 | 20, 21 | |
80 | 0.25 | 0.50a | 9.20 | ||||
70 | 0.29a | 0.58a | 7.83 | ||||
60 | 0.34a | 0.68a | 6.71 | ||||
50 | 0.37a | 0.75a | 6.09 | ||||
40 | 0.55a | 1.10a | 4.18 | ||||
30 | 0.57a | 1.15a | 4.00 | ||||
20 | 1.76a | 3.51a | 1.31 | ||||
0 | 1.91a | 3.82a | 1.20 | ||||
Plague | |||||||
Yersinia pestis A-1122 (HIBc and/or 1% peptone) | 2.0 × 109 cells/ml | 26 | 87 | 0.29 | 0.57 | 3.49 | 94 |
26 | 50 | 0.48 | 0.95 | 2.10 | |||
26 | 20 | 0.38 | 0.75 | 2.66 | |||
Smallpox | |||||||
Vaccinia virus (HIB) | Not listed | 10.5-11.5 | 20 | 275a | 551a | 0.00 | 40 |
10.5-11.6 | 50 | 123a | 246a | 0.00 | |||
10.5-11.7 | 80 | 47.2a | 94.4a | 0.02 | |||
21.0-23.0 | 20 | 30.7a | 61.4a | 0.03 | |||
21.0-23.1 | 50 | 26.5a | 53.0a | 0.03 | |||
21.0-23.2 | 80 | 7.70 | 15.4 | 0.13 | |||
31.0-33.5 | 20 | 30.9a | 61.9a | 0.03 | |||
31.0-33.6 | 50 | 8.63 | 17.3 | 0.11 | |||
Vaccinia virus (Mcllvaine buffer with 1% horse serum) | Not listed | 22 | 20 | 55.4a | 111a | 0.01 | 41 |
10 | 50 | 17.1 | 34.2a | 0.05 | |||
10 | 80 | 10.8 | 21.6 | 0.09 | |||
HFd | |||||||
Arenaviridae Venezuelan equine encephalomyelitis virus (HIB) | 1.0 × 1010 mouse IP LD50/ml | 9.0-9.5 | 19 | 146 | 291 | 0.00 | 40 |
9.0-9.5 | 48 | 36.8 | 73.7 | 0.02 | |||
9.0-9.5 | 86 | 19.5 | 39.0 | 0.05 | |||
21-23 | 19-23 | 21.9 | 43.8 | 0.04 | |||
21-23 | 50 | 9.53 | 19.1 | 0.10 | |||
21-23 | 81-86 | 8.06 | 16.1 | 0.12 | |||
20.5-23.5 | 19 | 11.0 | 21.9 | 0.09 | |||
20.5-23.5 | 48 | 4.38 | 8.76 | 0.22 | |||
20.5-23.5 | 81-85 | 1.16 | 2.32 | 0.86 | |||
Arenaviridae Lassa virus Josiah strain (Eagle's essential medium with Earle's salts and fetal bovine serum) | 6.3 × 106 PFU/ml | 24 | 30 | 0.89 | 1.79a | 1.12 | 81 |
24 | 55 | 0.92 | 1.85a | 1.08 | |||
24 | 80 | 0.70 | 1.42a | 1.41 | |||
32 | 30 | 1.47a | 2.94a | 0.68 | |||
32 | 55 | 1.67a | 3.33a | 0.60 | |||
32 | 80 | 1.79a | 3.58a | 0.55 | |||
38 | 30 | 1.68a | 3.36a | 0.59 | |||
Flaviviridae Japanese encephalitis virus Peking strain (HIB) | 24 | 30 | 5.59a | 11.2a | 0.17 | 52 | |
24 | 55 | 4.08a | 8.15a | 0.24 | |||
24 | 80 | 2.99a | 5.97a | 0.33 | |||
Flaviviridae St. Louis encephalitis Parton strain (bovine albumin, borate, saline) | 3.1 × 108 TCID50/ml | 80 | 7.29 | 14.6 | 0.13 | 71 | |
80 | 6.14 | 12.3 | 0.16 | ||||
60 | 11.5 | 23.0 | 0.08 | ||||
61 | 4.79 | 9.58 | 0.20 | ||||
46 | 12.7 | 25.4a | 0.07 | ||||
46 | 10.7 | 21.5 | 0.09 | ||||
35 | 25.6a | 51.1a | 0.03 | ||||
23 | 1,438 | 2,875 | 0.001 | ||||
Filoviridae Marburg virus (found not to be stable in air) | 3 | 7 |
Estimated T90 and T99 are beyond the time measured in the study.
PBS, phosphate buffer solution.
HIB, heart infusion broth.
HF, hemorrhagic fever.
HPAC, the Defense Threat Reduction Agency's hazard prediction and assessment capability.